In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 13, 2026), Finepoint Capital LP reported 5 stock positions worth $532.7 million . Its top holding was Qxo (QXO) at 76.7% of the portfolio, followed by Rxo (RXO, 22.3% ) and Solid Biosciences (SLDB, 1.0% ). Compared with Q3 2025, it added to 1 and reduced 1. The biggest buy was Rxo (RXO, shares +29% ) and the biggest sale Qxo (QXO, shares −5% ).
Location BOSTON, MA
CIK 0001608126
Portfolio Value $532.7M (Q4 2025) Holdings 5 stocks · $532.7M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q3 2025 QXO Qxo Inc. 76.69% 21,177,415 $408.5M Reduce -5.0% RXO Rxo Inc. 22.28% 9,388,789 $118.7M Add +29.2% SLDB Solid Biosciences Inc. 1.02% 961,251 $5.4M No change ANNA Aleanna Inc. 0.01% 27,717 $79K No change CLDI Calidi Biotherapeutics Inc. 0.00% 1,042 $1K No change
Options reported separately and not counted above: SPY puts ($1.1B), IWM puts ($398.0M).
Other holdings (2): bonds, preferreds, convertibles and warrants · $108K (not counted above) Security Class Shares / Principal Value Change ANNAW Aleanna Inc. Class A - 29 *W EXP 12/13/202 490,000 $69K No change MNYWW Moneyhero Ltd.-28 *W EXP 09/13/202 895,000 $38K No change
Total filed on the 13F, all lines: $532.8M.
Portfolio Sells Q3 2025 → Q4 2025 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2025 % Of Portfolio Change To Portfolio ▲ QXO Qxo Inc. Reduce -5.0% 76.69% −1.61
Portfolio Buys Q3 2025 → Q4 2025 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2025 % Of Portfolio Change To Portfolio ▼ RXO Rxo Inc. Add +29.2% 22.28% +1.69
Options Activity Q3 2025 → Q4 2025 Security Type Change vs Q3 2025 Underlying Shares Value ▼ SPY SS SPDR S&P 500 ETF Trust-US put Add +30.3% 1,573,200 $1.1B
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 4 $460.8M QXO, RXO, ANNA, CLDI Q1 2026 4 $416.6M QXO, RXO, ANNA, CLDI Q4 2025 5 $532.7M QXO, RXO, SLDB, ANNA, CLDI Q3 2025 5 $542.8M QXO, RXO, SLDB, ANNA, CLDI Q2 2025 5 $504.1M QXO, LLYVK, SLDB, ANNA, CLDI Q1 2025 19 $592.5M QXO, LBRDK, SWTX, LLYVK, ASND Q4 2024 20 $866.7M QXO, LBRDK, LLYVK, ARGX, RVMD Q3 2024 18 $822.2M QXO, LBRDK, RVMD, ARGX, ASND Q2 2024 17 $351.8M LBRDK, RVMD, ASND, SWTX, ARGX Q1 2024 17 $376.0M LBRDK, SWTX, ASND, ARVN, RVMD